Company news
Treace Medical Concepts, Inc. (NASDAQ:TMCI) news
Treace Medical Concepts, Inc. news releases on 6ix. Latest, Sep 17, 2026: Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year…
Press releases & updates
Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
September 17, 2026
Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting
September 15, 2026
Treace Medical Concepts Reports Second Quarter 2026 Financial Results
August 7, 2026
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
July 24, 2026
Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
June 18, 2026
Treace to Present at the Sidoti Small Cap Conference
June 10, 2026
Treace Medical Concepts Reports First Quarter 2026 Financial Results
May 8, 2026
Treace to Report First Quarter 2026 Financial Results on May 8, 2026
April 24, 2026
Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System
April 6, 2026
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results
March 2, 2026
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results
February 27, 2026
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
February 24, 2026
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
February 12, 2026
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
January 13, 2026
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
January 8, 2026
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference
December 30, 2025
Treace Medical Secures Up to $175 Million in Debt Financing
December 18, 2025
Treace Announces Participation in Two Upcoming Investor Conferences
November 7, 2025
Treace Medical Concepts Reports Third Quarter 2025 Financial Results
November 6, 2025
Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
October 23, 2025
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting
September 10, 2025
Treace Medical Concepts Reports Second Quarter 2025 Financial Results
August 7, 2025
Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025
August 7, 2025
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study
August 5, 2025
Treace to Report Second Quarter 2025 Financial Results on August 7, 2025
July 24, 2025
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
June 5, 2025
Treace Medical Concepts Reports First Quarter 2025 Financial Results
May 8, 2025
Treace to Report First Quarter 2025 Financial Results on May 8, 2025
April 24, 2025
Treace Announces Upcoming Board Chair Transition
April 7, 2025
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference
March 28, 2025
Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference
March 25, 2025
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2024 Financial Results
February 27, 2025
Treace Announces First Surgical Cases Utilizing the SpeedAkin™ Anatomic Compression Implant
January 29, 2025
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue
January 12, 2025
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure
December 29, 2024
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
December 15, 2024
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities
December 3, 2024
Treace Appoints Guy Guglielmino as Chief Commercial Officer
December 1, 2024
Treace Medical Concepts Reports Third Quarter 2024 Financial Results
November 4, 2024
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
November 3, 2024
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
October 21, 2024
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
October 13, 2024
Treace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024
September 10, 2024
Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 21, 2024
Treace Medical Concepts Reports Second Quarter 2024 Financial Results
August 5, 2024
Treace Medical Concepts Reports First Quarter 2024 Financial Results
May 6, 2024
Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour
April 23, 2024
Treace Announces First Annual National Bunion Day
April 15, 2024
Treace to Report First Quarter 2024 Financial Results
April 8, 2024
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
March 24, 2024